Drug Pipeline

Busulfan test dose Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT04339777 Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity Lymphoproliferative Disorders Recruiting
NCT05027945 A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS… Immunodeficiency Recruiting
NCT01861106 Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations GATA2 Recruiting
Sponsors Running Busulfan test dose Trials
National Cancer Institute (NCI) (3)
Disease Areas
Myelodysplastic Syndromes (MDS) (1)
Get alerts when Busulfan test dose trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free